(Headquarters: Tokyo, CEO: Haruo Naito, 'Eisai') will launch Etak Antimicrobial Wet Wipes (classified as miscellaneous goods) containing long-acting
antimicrobial agent Etak on August 29, 2019 at pharmacies and drugstores countrywide.
M2 PHARMA-August 23, 2019-ViiV Healthcare Reports Positive Phase III Study Results of Investigational, Long-acting
, Injectable HIV-Treatment Regimen Administered Every Two Months
ViiV Healthcare, a company majority owned by GSK (GS), with Pfizer (PFE), and Shionogi Limited as shareholders, announced positive headline results from its global phase III ATLAS-2M study of the investigational, long-acting
, injectable, 2-drug regimen, or 2DR, of ViiV Healthcare's cabotegravir and Janssen's rilpivirine for the treatment of HIV.
insulin plus sulfonylurea and age 75 years or older were negatively associated with hypoglycemia.
If approved, this long-acting
, injectable regimen of cabotegravir and rilpivirine has the potential to give people living with HIV one month between doses with similar safety and efficacy as today's standard of care-an oral, 3-drug regimen taken everyday.
GS-6207 is an investigational long-acting
antiretroviral agent that can be delivered subcutaneously.
New use of inhaled long-acting
beta, agonists or long-acting
antimuscarinic antagonists was associated with a 1.5-fold increased cardiovascular risk within 30 days of initiation in patients with chronic obstructive pulmonary disease, irrespective of prior cardiovascular disease status and history of exacerbations, according to a review of more than 280,000 COPD patients in Taiwan.
That approach came as news to many meeting attendees, based on results of an audience poll in which 76% of attendees picked triple therapy for a 65-year-old male with COPD and frequent exacerbations who was taking only a long-acting
muscarinic antagonist (LAMA).
That approach came as news to many internists, at least going by results of an audience poll in which 76% of attendees picked triple therapy for a 65-year-old male with COPD and frequent exacerbations despite having used a long-acting
muscarinic antagonist (LAMA).
The product is a fixed-dose LAMA/LABA combination of the long-acting
muscarinic antagonist (LAMA) aclidinium and the long-acting
beta agonist (LABA) formoterol, administered via a PRESSAIR multi-dose inhaler.
Ultibro Breezhaler is an inhaled once-daily fixed-dose combination of indacaterol (a long-acting
beta 2 agonist; LABA) and glycopyrronium bromide (a long-acting
muscarinic antagonist; LAMA) and Seebri Breezhaler is an inhaled fixed-dose formulation of glycopyrronium bromide (a long-acting
muscarinic antagonist; LAMA).
ViiV Healthcare presented comprehensive 48-week data from the ATLAS (Antiretroviral Therapy as Long-Acting
Suppression) and FLAIR (First Long-Acting
Injectable Regimen) pivotal phase III studies of the novel, investigational, long-acting
regimen of cabotegravir and rilpivirine.